Tin tức & Cập nhật
Lọc theo Chuyên ngành:
Obesity, diabetes, family history up prostate cancer risk in IBD patients
A longitudinal national database study of patients with inflammatory bowel disease (IBD) has identified several risk factors for the development of prostate cancer (PC), including age, obesity, diabetes, married status, family history of PC, and African American race.
Obesity, diabetes, family history up prostate cancer risk in IBD patients
10 Feb 2022
IBD patients anxious over severe COVID-19 risk
Patients with inflammatory bowel disease (IBD) report that the COVID-19 pandemic is a “major concern” for them, reveals a study, noting that the cumulative prevalence is low in this cohort. At-risk patients must be identified and counseled individually.
IBD patients anxious over severe COVID-19 risk
10 Feb 2022
Pfizer/BioNTech shots effective in IBD patients
The Pfizer-BNT162b2 vaccine for the coronavirus disease 2019 (COVID-19) effectively reduces the risk of serious outcomes and hospitalization in patients with inflammatory bowel diseases (IBD), though with slight variance in effectivity with respect to ongoing medications, reports a Qatar study presented at the recently concluded 2022 Crohn’s & Colitis Congress (CCC 2022).
Pfizer/BioNTech shots effective in IBD patients
10 Feb 2022
Extensive influenza testing needed in pneumonia patients
Most patients with community-acquired pneumonia go untested for influenza even during flu season, which is unfortunate since a positive test result facilitates antiviral therapy, and early treatment leads to lower mortality, according to a study.
Extensive influenza testing needed in pneumonia patients
10 Feb 2022
Less is more when treating benign prostatic hyperplasia with thermal water vapour
Thermal water vapour therapy that consists of a single injection per prostate lobe for benign prostatic hyperplasia (BPH) is both effective and safe, yielding similar improvements in lower urinary tract symptoms and quality of life when compared with a traditional approach that employed variable number of injections by prostate volume, as shown in a study.
Less is more when treating benign prostatic hyperplasia with thermal water vapour
10 Feb 2022
Casirivimab-imdevimab combo prevents progression from asymptomatic to symptomatic COVID-19
Treatment with the combination therapy of casirivimab and imdevimab prevents the risk of developing symptomatic COVID-19 among asymptomatic individuals with SARS-CoV-2 infection in a household close-contact setting, according to a recent study.
